Dyax, Affymax Technologies N.V., The Burnham Institute, Corvas, Glaxo Wellcome, MorphoSys GmbH, Novagen Inc. deal

Affymax, Burnham, CVAS, Glaxo, MorphoSys and Novagen each received a non-exclusive license to Dyax's phage display technology in human therapeutics and in certain in vitro diagnostic and research prod...